Dr. Jeff Jones from OSU on ibrutinib resistance, combination therapy and treating asymptomatic CLL.

[bkoffman]

Friends,

Today on our website: cllsociety.org we share an interview with another doctor from Ohio State University, Dr. Jeff Jones, to discuss ibrutinib resistance, combination therapy and treating asymptomatic CLL.

Our inaugural newsletter web site, "The CLL Tribune" was launched on Sept. 30th and the response has been wonderful. We owe profound thanks to our CLL Expert authors, John Byrd and Jennifer Brown, and our patient and caregiver authors, Linda Lannom, Ken Martin, Erin Michaela Sweeney, Mark Silverstein, Wayne Wells, and Kate Woronowicz. We are already putting together the next issue scheduled to be rolled out by the end of the year. If you haven't had a chance to peruse it, you can find it here: cllsociety.org/newsletter/

We will be busy posting a backlog of great lectures and interviews (like this with Dr. Jones) and articles on CLL once and often twice a week over the next few months leading up to ASH so please check in on the website regulaly or sign up for the alerts here: cllsociety.org/newsletter-s....

Finally we are planning a post-ASH patient education forum and CLL Society LA support group launch in conjunction with City of Hope and LLS on Dec. 12, 2015. More details to follow.

Stay strong.

We are all in this together.

Brian Koffman

[Justasheet1]

Thanks Doc. Keep them coming. I hope you are feeling well.

Jeff

[jangreen]

Hi here's I guy who's saying what we all want to hear. Thanks. Best wishes

[bkoffman CLL CURE Hero in reply to jangreen]

Agree.